Brokerages Set The Cooper Companies, Inc. (NASDAQ:COO) Target Price at $99.70

The Cooper Companies, Inc. (NASDAQ:COO) has received an average recommendation of “Moderate Buy” from the eleven analysts that are covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $99.70.

COO has been the topic of a number of research reports. Needham & Company LLC upgraded Cooper Companies from a “hold” rating to a “buy” rating and set a $94.00 price objective on the stock in a report on Tuesday, June 17th. Wells Fargo & Company dropped their price objective on Cooper Companies from $118.00 to $93.00 and set an “overweight” rating on the stock in a report on Friday, May 30th. Wall Street Zen upgraded Cooper Companies from a “hold” rating to a “buy” rating in a report on Friday, June 27th. BNP Paribas upgraded Cooper Companies to a “hold” rating in a report on Thursday, March 13th. Finally, UBS Group upgraded Cooper Companies to a “buy” rating in a report on Tuesday, June 17th.

Cooper Companies Price Performance

COO stock opened at $73.01 on Thursday. The company has a current ratio of 2.10, a quick ratio of 1.23 and a debt-to-equity ratio of 0.30. Cooper Companies has a one year low of $65.00 and a one year high of $112.38. The firm has a market capitalization of $14.60 billion, a PE ratio of 35.44, a P/E/G ratio of 1.79 and a beta of 0.99. The firm has a 50-day moving average of $75.62 and a two-hundred day moving average of $83.26.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, beating analysts’ consensus estimates of $0.93 by $0.03. The company had revenue of $1 billion during the quarter, compared to analyst estimates of $995.12 million. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The business’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period in the prior year, the firm earned $0.85 earnings per share. On average, analysts forecast that Cooper Companies will post 3.98 earnings per share for the current year.

Hedge Funds Weigh In On Cooper Companies

Hedge funds have recently made changes to their positions in the business. Zions Bancorporation National Association UT acquired a new stake in shares of Cooper Companies during the 1st quarter worth about $33,000. OFI Invest Asset Management acquired a new stake in shares of Cooper Companies during the 4th quarter worth about $34,000. City Holding Co. acquired a new stake in shares of Cooper Companies during the 1st quarter worth about $34,000. New Age Alpha Advisors LLC acquired a new stake in shares of Cooper Companies during the 4th quarter worth about $38,000. Finally, GKV Capital Management Co. Inc. acquired a new stake in shares of Cooper Companies during the 1st quarter worth about $40,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.